Until now, continuous glucose monitoring has been considered an advanced option for the treatment of diabetes. Most people with diabetes, Type 1 or Type 2, don’t wear continuous glucose monitors, and to get insurance coverage for them, most people must demonstrate that they have a troublesome history of hypoglycemia (low blood glucose).
Wearables are gearing up to land on different parts of your body and measure things far beyond the step count that their developers say will be far more actionable.
Three former Dexcom employees left the company last year to form a new venture, Glucovation, which is developing a direct-to-consumer, wearable device that continuously senses glucose for people trying to lose weight or improve their athletic performance. The Glucovation team is headed up by Dexcom’s former senior technical director for R&D, Robert Boock, who was
DC Rainmaker: CES Roundup Part 2: Garmin, ANT+, 4iiii, BKOOL, Withings, O-Synce, Outside Interactive, LG, Pebble, Casio, Opryx, Glucovation
DC Rainmaker writes about Glucovation’s innovative approach to glucose sensing. “It’s designed for athletic/sport use – so no problems with water, etc…